These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29174027)
1. Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status. Hu X; Xiong Q; Xu Y; Zhang X; Pan X; Ma X; Bao Y; Jia W Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):119-125. PubMed ID: 29174027 [TBL] [Abstract][Full Text] [Related]
2. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women. Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752 [TBL] [Abstract][Full Text] [Related]
3. Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels. Fang Q; Li H; Song Q; Yang W; Hou X; Ma X; Lu J; Xu A; Jia W Diabetes Care; 2013 Sep; 36(9):2810-4. PubMed ID: 23628619 [TBL] [Abstract][Full Text] [Related]
4. Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? Chen P; Hou X; Hu G; Wei L; Jiao L; Wang H; Chen S; Wu J; Bao Y; Jia W Cardiovasc Diabetol; 2018 Jun; 17(1):93. PubMed ID: 29945626 [TBL] [Abstract][Full Text] [Related]
5. Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation. Hu X; Ma X; Luo Y; Xu Y; Xiong Q; Pan X; Xiao Y; Bao Y; Jia W Clin Nutr; 2018 Feb; 37(1):223-228. PubMed ID: 28027796 [TBL] [Abstract][Full Text] [Related]
6. Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner. Zhang J; Li H; Bai N; Xu Y; Song Q; Zhang L; Wu G; Chen S; Hou X; Wang C; Wei L; Xu A; Fang Q; Jia W J Endocrinol Invest; 2019 Sep; 42(9):1019-1027. PubMed ID: 30852757 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and body fat distribution. Yamashita S; Nakamura T; Shimomura I; Nishida M; Yoshida S; Kotani K; Kameda-Takemuara K; Tokunaga K; Matsuzawa Y Diabetes Care; 1996 Mar; 19(3):287-91. PubMed ID: 8742584 [TBL] [Abstract][Full Text] [Related]
8. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes. Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902 [TBL] [Abstract][Full Text] [Related]
9. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262 [TBL] [Abstract][Full Text] [Related]
10. Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. Borel AL; Nazare JA; Smith J; Aschner P; Barter P; Van Gaal L; Eng Tan C; Wittchen HU; Matsuzawa Y; Kadowaki T; Ross R; Brulle-Wohlhueter C; Alméras N; Haffner SM; Balkau B; Després JP Int J Obes (Lond); 2015 Mar; 39(3):495-501. PubMed ID: 25179244 [TBL] [Abstract][Full Text] [Related]
11. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368 [TBL] [Abstract][Full Text] [Related]
12. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients. Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987 [TBL] [Abstract][Full Text] [Related]
13. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Indulekha K; Anjana RM; Surendar J; Mohan V Clin Biochem; 2011 Mar; 44(4):281-7. PubMed ID: 21219897 [TBL] [Abstract][Full Text] [Related]
14. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Hwang YC; Woo Oh S; Park SW; Park CY Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853 [TBL] [Abstract][Full Text] [Related]
15. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance]. Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458 [TBL] [Abstract][Full Text] [Related]
16. Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. Giannini C; Feldstein AE; Santoro N; Kim G; Kursawe R; Pierpont B; Caprio S J Clin Endocrinol Metab; 2013 Jul; 98(7):2993-3000. PubMed ID: 23626003 [TBL] [Abstract][Full Text] [Related]
17. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais. Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686 [TBL] [Abstract][Full Text] [Related]
18. Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders. Zheng J; Liu J; Hong BS; Ke W; Huang M; Li Y BMC Endocr Disord; 2020 Apr; 20(1):51. PubMed ID: 32299395 [TBL] [Abstract][Full Text] [Related]
19. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452 [TBL] [Abstract][Full Text] [Related]
20. Liver fat, visceral adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients. Sakkas GK; Karatzaferi C; Zintzaras E; Giannaki CD; Liakopoulos V; Lavdas E; Damani E; Liakos N; Fezoulidis I; Koutedakis Y; Stefanidis I Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1721-9. PubMed ID: 18832089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]